BR1100847A - Derivados de 2- [4 - (4-azolilbutil) -1- piperazinil] -pirimidina, compostos, processo de preparação dos compostos, utilização dos compostos, e, composições farmacêuticas - Google Patents

Derivados de 2- [4 - (4-azolilbutil) -1- piperazinil] -pirimidina, compostos, processo de preparação dos compostos, utilização dos compostos, e, composições farmacêuticas

Info

Publication number
BR1100847A
BR1100847A BR1100847-4A BR1100847A BR1100847A BR 1100847 A BR1100847 A BR 1100847A BR 1100847 A BR1100847 A BR 1100847A BR 1100847 A BR1100847 A BR 1100847A
Authority
BR
Brazil
Prior art keywords
compounds
azolylbutyl
piperazinyl
pharmaceutical compositions
pyrimidine derivatives
Prior art date
Application number
BR1100847-4A
Other languages
English (en)
Inventor
Jordi Frigola-Constansa
Ramon Merce-Vidal
Original Assignee
Jordi Frigola-Constansa
Ramon Merce-Vidal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordi Frigola-Constansa, Ramon Merce-Vidal filed Critical Jordi Frigola-Constansa
Publication of BR1100847A publication Critical patent/BR1100847A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR1100847-4A 1993-02-05 1997-05-12 Derivados de 2- [4 - (4-azolilbutil) -1- piperazinil] -pirimidina, compostos, processo de preparação dos compostos, utilização dos compostos, e, composições farmacêuticas BR1100847A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9301293A FR2701260B1 (fr) 1993-02-05 1993-02-05 Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.

Publications (1)

Publication Number Publication Date
BR1100847A true BR1100847A (pt) 1999-12-07

Family

ID=9443776

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100847-4A BR1100847A (pt) 1993-02-05 1997-05-12 Derivados de 2- [4 - (4-azolilbutil) -1- piperazinil] -pirimidina, compostos, processo de preparação dos compostos, utilização dos compostos, e, composições farmacêuticas

Country Status (15)

Country Link
US (1) US5444059A (pt)
EP (1) EP0610140B1 (pt)
JP (1) JPH06234762A (pt)
KR (1) KR940019705A (pt)
AT (1) ATE188693T1 (pt)
AU (1) AU684479B2 (pt)
BR (1) BR1100847A (pt)
CA (1) CA2115016A1 (pt)
DE (1) DE69422532D1 (pt)
ES (1) ES2076894B1 (pt)
FR (1) FR2701260B1 (pt)
HU (1) HU218211B (pt)
NO (1) NO305082B1 (pt)
RU (1) RU2118318C1 (pt)
ZA (1) ZA94775B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712392A (en) * 1990-12-28 1998-01-27 Neurogen Corporation Certain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
US6011052A (en) * 1996-04-30 2000-01-04 Warner-Lambert Company Pyrazolone derivatives as MCP-1 antagonists
US6166205A (en) * 1998-09-02 2000-12-26 Neurogen Corporation 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
DE19951960C2 (de) * 1999-10-28 2002-06-27 Gruenenthal Gmbh Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
KR100465649B1 (ko) * 2002-09-17 2005-01-13 한국포리올 주식회사 일체형 연마 패드 및 그 제조 방법
PT1651620E (pt) * 2003-07-30 2012-02-10 Xenon Pharmaceuticals Inc Derivados de piperizina e sua utilização como agentes terapêuticos
WO2011030139A1 (en) 2009-09-11 2011-03-17 Astrazeneca Ab 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US5187276A (en) * 1983-06-18 1993-02-16 Troponwerke Gmbh & Co. Kg. 2-pyrimidinyl-1-piperazine derivatives
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2654621B1 (fr) * 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
DE69116302T2 (de) * 1990-10-23 1996-05-30 Akzo Nobel Nv 4-[4- oder 6-(Trifluormethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituierte Laktame
FR2671972B1 (fr) * 1991-01-25 1995-03-03 Esteve Labor Dr Utilisation de derives 1-h-azole-(omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl) pour la preparation de medicaments destines au traitement des troubles des fonctions cognitives.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .

Also Published As

Publication number Publication date
RU2118318C1 (ru) 1998-08-27
JPH06234762A (ja) 1994-08-23
FR2701260B1 (fr) 1995-05-05
EP0610140A1 (fr) 1994-08-10
AU684479B2 (en) 1997-12-18
US5444059A (en) 1995-08-22
FR2701260A1 (fr) 1994-08-12
NO940274D0 (no) 1994-01-26
NO305082B1 (no) 1999-03-29
HU9400321D0 (en) 1994-05-30
EP0610140B1 (fr) 2000-01-12
NO940274L (no) 1994-08-08
CA2115016A1 (fr) 1994-08-06
AU5488994A (en) 1994-08-11
ES2076894A1 (es) 1995-11-01
HUT70196A (en) 1995-09-28
ES2076894B1 (es) 1996-10-16
ATE188693T1 (de) 2000-01-15
HU218211B (hu) 2000-06-28
ZA94775B (en) 1994-09-29
DE69422532D1 (de) 2000-02-17
KR940019705A (ko) 1994-09-14

Similar Documents

Publication Publication Date Title
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
ATE248837T1 (de) Chinuclidin-acrylamide
CA2216796A1 (en) Quinazoline derivatives
BR9205811A (pt) Derivados heterociclicos de aminas ciclicas
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
BR1100847A (pt) Derivados de 2- [4 - (4-azolilbutil) -1- piperazinil] -pirimidina, compostos, processo de preparação dos compostos, utilização dos compostos, e, composições farmacêuticas
PT992509E (pt) Novos derivados macrolidos
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
ATE110365T1 (de) 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel.
NO960632L (no) Nye bis-naftalimider for behandling av kreft
EP0410114A3 (en) Use of 4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)-1-(4-fluorophenyl)-butanol in pharmaceutical compositions for the treatment of ischemia in brain
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
RU94003397A (ru) Производные 2-/4-(4-азолилбутил)-1-пиперазинил/-пиримидина, способ их получения и фармацевтическая композиция на их основе
SE9902937D0 (sv) Pharmaceutical compositions
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
PT99091A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da triazina e da pirimidina, como ingredientes activos, destinadas a reverter a resistencia aos agentes anticancerosos e antimalaricos
HUP9900401A3 (en) Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases, pharmaceutical compositions containing them and their use
FI883455A (fi) Leukotrienantagonister, foerfaranden foer deras framstaellning, deras anvaendning vid behandling av sjukdomar samt foerprodukter.
DE59104473D1 (de) Arzneimittel welche substituierte 2-Cyclohexen-1yl-amin-Derivate enthalten und ihre Verwendung zur Bekämpfung von Krankheiten.
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
EP1547603A3 (en) Compositions and methods for use in targeting vascular destruction
IT1248669B (it) Derivato di idrossiprolina, sua preparazione e composizioni farmaceutiche che lo contengono
ITMI911343A0 (it) Composizioni farmaceutiche per il trattamento di dermatosi

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96